Opaleye Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Opaleye Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-281,600	Closed	-$2.22M	–	57
2020 Q1	$2.22M	Sell	281,600 -133,900	-32%	-$2.02M	0.59%	35
2019 Q4	$8.6M	Buy	415,500 +310,500	+296%	+$5.24M	1.69%	27
2019 Q3	$1.44M	Buy	+105,000	New	+$1.25M	0.52%	40
2014 Q2	–	Sell	-135,500	Closed	-$2.23M	–	35
2014 Q1	$2.23M	Buy	+135,500	New	+$2.34M	1.65%	19

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Opaleye Management's FLXN Position: Q2 2020 in Review

Opaleye Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2020, closing a stake of 281,600 shares — an estimated $2.22M sold.

Opaleye Management first reported a position in FLXN in Q1 2014 and held it in 4 quarters. The position peaked at $8.6M in Q4 2019. 125 funds tracked by Wall St. Rank hold FLXN as of Q2 2020.

Opaleye Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Opaleye Management sold 281,600 Flexion Therapeutics, Inc. shares in Q2 2020, an estimated $2.22M.
Opaleye Management first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 4 quarters.
Opaleye Management's Flexion Therapeutics, Inc. position peaked at $8.6M in Q4 2019.
125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2020.

Based on Opaleye Management's 13F filing for Q2 2020, filed 14 Aug 2020.